Exelixis EXEL
NASDAQ EXEL
$58.39 +0.45 (+0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exelixis (EXEL) Non Operating Investment Income (2011)

Updated

Exelixis' Non Operating Investment Income came in at $44,000 for Q4 2011, down 98.0% from the prior quarter.

Analysis

Exelixis (EXEL) Non Operating Investment Income (2011) Analysis & Trends

For FY2011, Exelixis' Non Operating Investment Income was $2.25 million, down 72.5% from FY2010.

  • Going back by year, Non Operating Investment Income was $8.2 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Exelixis 14.53 Bn 10.87 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 44,000.00
Sep 30, 2011 2.21 Mn
API Access

Exelixis Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=EXEL&period=max&api_key=YOUR_API_KEY